Navigation Links
Topical treatment for age spots, from Harvard Women's Health Watch
Date:12/5/2007

BOSTON, Dec. 5 /PRNewswire-USNewswire/ -- Sun-induced skin damage can cause brown age spots, especially on oft-exposed areas like the hands and face. At one time, the only remedy was to cover them up with cosmetics. Now, there are therapies that help reverse the signs of photoaging at the physiological level. One approach is physical removal by surgery, microdermabrasion, or chemical peel. But many women prefer something gentler, and topical medications can help, reports the December 2007 issue of Harvard Women's Health Watch.

The topical drugs used for treating age spots work mainly by interrupting the formation of melanin, the pigment responsible for tanning. To get the best results, you should also use a sunscreen with an SPF of 30 or higher. Harvard Women's Health Watch describes the following commonly used agents.

Hydroquinone. Many dermatologists consider this cream the best choice for treating age spots. You can expect to see results in four to six weeks, with the greatest improvement after four to six months. The most common side effect is irritation or reddening. The FDA recently proposed a ban on over-the-counter preparations containing hydroquinone because studies found that the drug may cause cancer when fed to rats and mice. So far, there are no studies showing any increased risk to humans using the drug topically. The FDA is still responding to challenges from critics who oppose the ban.

Tretinoin. Topical tretinoin was first approved for treating acne, but trials have demonstrated that it also improves photoaged skin. It can take several months to lighten age spots, and side effects include redness, scaling, and itchiness, although these generally subside after a few weeks. Brand names include Retin-A, Renova, and Avita.

Adapalene gel. This prescription drug is approved only for treating acne, but sometimes it is used off-label to improve photoaged skin.

Also in this issue:

-- Hormone therapy's risks and benefits

-- Herbs and supplements for anxiety

-- Slowing age-related macular degeneration

-- By the way, doctor: Do I need a cholesterol-lowering drug? Why do I yawn during exercise?

Harvard Women's Health Watch is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $24 per year. Subscribe at http://www.health.harvard.edu/women or by calling 877-649-9457 (toll-free).


'/>"/>
SOURCE Harvard Women's Health Watch
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
2. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
3. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
4. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
5. New treatment effective in counteracting cocaine-induced symptoms
6. New treatment boosts muscle function in myasthenia gravis
7. Broad-based group of physicians calls for improvement in stroke treatment
8. Cranberry Could Juice Up Ovarian Cancer Treatment
9. Non-medicinal treatment touted for pre-schoolers with ADHD
10. Nonmedicinal treatment touted for preschoolers with ADHD
11. U of M study: Early treatment can reverse heart damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... Clara, CA (PRWEB) , ... April 28, 2017 ... ... is pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep ... user experience, since it streamlines the reporting process and provides a familiar interface ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: